TickerFacts.

NRX Pharmaceuticals, Inc. (NRXP): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2024-05-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

31.73M
As of 2025-12-31
43.16M
As of 2026-06-30
66.44M2017-12-31: 2.59M2018-12-31: 2.73M2019-12-31: 2.84M2020-12-31: 42.97M2021-12-31: 58.81M2022-12-31: 66.44M2023-12-31: 8.39M2024-12-31: 14.59M2025-12-31: 31.73M31.73M
2017-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-3131.73M+117.5%2026-03-23, Balance as of period end
2024-12-3114.59M+73.9%2026-03-23, Balance as of period end
2023-12-318.39Mn/c2025-03-14, Balance as of period end
2022-12-3166.44M+13.0%2024-03-29, Balance as of period end
2021-12-3158.81M+36.9%2023-03-31, Balance as of period end
2020-12-3142.97Mn/m2022-03-31, Balance as of period end
2019-12-312.84Mn/c2021-05-14, Balance as of period end
2018-12-312.73M+5.2%2020-03-30, Balance as of period end
2017-12-312.59Mn/a2019-03-15, Balance as of period end